DOCSLIB.ORG

Mutagenesis of a Functional Chimeric Gene in Yeast Identifies Mutations in the Simian Virus 40 Large T Antigen J Domain

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mutagenesis of a Functional Chimeric Gene in Yeast Identifies Mutations in the Simian Virus 40 Large T Antigen J Domain Mutagenesis of a functional chimeric gene in yeast identifies mutations in the simian virus 40 large T antigen J domain Sheara W. Fewell, James M. Pipas, and Jeffrey L. Brodsky† Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260 Communicated by Mary Edmonds, University of Pittsburgh, Pittsburgh, PA, December 14, 2001 (received for review July 2, 2001) Simian virus 40 large T antigen contains an amino terminal J Escherichia coli (27) and the J domains from two human DnaJ domain that catalyzes T antigen-mediated viral DNA replication homologs can substitute for the amino terminus of T antigen in and cellular transformation. To dissect the role of the J domain in promoting viral DNA replication (21) or enhancing Tst-1 tran- these processes, we exploited the genetic tools available only in scription factor activity (28). Because T antigen inactivates the yeast Saccharomyces cerevisiae to isolate 14 loss-of-function normal cellular growth controls by altering the retinoblastoma point mutations in the T antigen J domain. This screen also (Rb) family of tumor suppressors (pRb, p107, and p130) and p53 identified mutations that, when engineered into simian virus 40, (26, 29–31), we proposed that T antigen performs its diverse resulted in T antigen mutants that were defective for the ability to functions by recruiting cellular hsc70 to modulate the activities support viral growth, to transform mammalian cells in culture, to of these multiprotein complexes (32). However, validation of this dissociate the p130–E2F4 transcription factor complex, and to ‘‘chaperone model’’ requires the correlation of in vivo T antigen- stimulate ATP hydrolysis by hsc70, a hallmark of J domain-contain- mediated phenotypes with biochemical measurements of T ing molecular chaperones. These data correlate the chaperone antigen chaperone activity. To accomplish this goal, we estab- activity of the T antigen J domain with its roles in viral infection and lished a genetic screen in yeast from which T antigen mutants cellular transformation and support a model by which the viral J compromised for SV40 growth and the ability to promote domain recruits the cytoplasmic hsc70 molecular chaperone in the cellular transformation were identified. Biochemical measure- host to rearrange multiprotein complexes implicated in replication ments of the purified wild-type and mutant T antigens indicated and transformation. More generally, this study presents the use of that these mutants were defective for the stimulation of hsc70 a yeast screen to identify loss-of-function mutations in a mamma- ATPase activity. This study also describes the random mutagen- lian virus and can serve as a widely applicable method to uncover esis of a J domain toward the goal of identifying noncomple- domain functions of mammalian proteins for which there are yeast menting mutants. homologues with selectable mutant phenotypes. Materials and Methods sp40–hsc70 molecular cochaperones modulate the confor- Plasmid Construction and Genetic Screen. The Saccharomyces cer- Hmations of polypeptide substrates to perform diverse func- evisiae strain ACY17b (MAT␣ ade2–1 leu2–3 112, his3–11 15 tions including the folding of nascent polypeptides, the transport trp1–1 ura3–1 can1–100 ydj1–2::HIS3 LEU2::ydj1–151; ref. 33) of proteins across organellar membranes, and the rearrangement was manipulated by standard procedures (34). The chimeric of multiprotein complexes (1). Members of the hsp40 family are T-Ydj1 fusion was created by sequential PCRs. In the first round, Ϸ defined molecularly by the presence of an 70-aa motif called oligonucleotides TJ1A (see Table 2, which is published as the J domain and biochemically by their ability to stimulate ATP supporting information on the PNAS web site, www.pnas.org, for hydrolysis by hsc70 partner chaperones. Hsc70s bind and release oligonucleotide sequences) and TJ3B were used to amplify DNA polypeptide substrates through the coordinated actions of their encoding the T antigen J domain with an EcoRI site at the 5Ј end amino-terminal ATPase and carboxyl-terminal substrate- and a short sequence complementary to the region downstream binding domains; transient interactions between ATP-bound of the YDJ1 J domain at the 3Ј end. In the second PCR step, hsc70 and polypeptide substrates are stabilized upon ATP DNA encoding residues 82–409 of YDJ1 from pAV6 (obtained hydrolysis (2–4). The J domain of hsp40 chaperones directly from A. Caplan, Mount Sinai School of Medicine, New York) interacts with the ATPase domain of hsc70s and regulates the and a NotI site at the 3Ј end was amplified with oligonucleotides affinity of hsc70 for its substrates by stimulating ATP hydrolysis TJ3A and TJ2B. In the final PCR, the products from the first two (5–7). Other domains in hsp40s may bind specific substrates and amplifications were fused, and the resulting fragment was di- target them to hsc70 (8–11). gested with EcoRI and NotI and cloned into the EcoRI and NotI Structural studies on four hsp40 homologs define a common sites of pYes2 (Invitrogen) to create pT-Ydj1. Mutant T-Ydj1 element in the J domain (12–15). J domains consist of four constructs were generated similarly with dl1135 (35), P43L͞ ␣-helices arranged such that the antiparallel second and third K45N, or D44E͞G47R (provided by Kathy Rundell, Northwest- helices form a finger-like projection. An invariant HPD se- ern University School of Medicine, Chicago) T antigen con- quence located in the loop connecting the second and third helices is critical for the interaction with and stimulation of hsc70 structs as template DNA in the initial PCR. The mutations in the (16, 17), but additional residues on the surface of helix II may J domains in each of these constructs were confirmed by DNA also contact hsc70 (18). sequence analysis. The large tumor antigen of simian virus 40 (SV40) T antigen To screen for T antigen J domain mutants, the J domain in contains a J domain that is essential for most aspects of SV40 infection and contributes to the transformation of cultured Abbreviations: SV40, simian virus 40; Rb, retinoblastoma. rodent cells and the promotion of tumorigenesis in transgenic †To whom reprint requests should be addressed at: 257 Crawford Hall, University of mice (19–23). Wild-type T antigen associates directly with hsc70 Pittsburgh, Pittsburgh, PA 15260. E-mail: [email protected]. in vivo and in vitro (24, 25) and is capable of stimulating hsc70 The publication costs of this article were defrayed in part by page charge payment. This ATPase activity in vitro (22, 26). In addition, the T antigen J article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. domain can functionally replace the J domain of DnaJ in §1734 solely to indicate this fact. 2002–2007 ͉ PNAS ͉ February 19, 2002 ͉ vol. 99 ͉ no. 4 www.pnas.org͞cgi͞doi͞10.1073͞pnas.042670999 Downloaded by guest on September 28, 2021 pT-Ydj1 was mutagenized by modified error-prone PCR (36). confirmed by Immunoblot analysis using mAb419, and stored at Two sets of PCRs containing A or G at a final concentration of Ϫ20°C. Wild type and each mutant T antigen were purified at 20 ␮M and the other deoxynucleotides at 200 ␮M were per- least twice for biochemical studies. At initial time points, yeast- formed with oligonucleotides SWF3 and SWF4 and TaqDNA purified T antigen stimulated Hsc70 ATPase activity comparably polymerase (Roche Molecular Biochemicals). DNA from mul- to T antigen from insect cells (40), and more than 90% of the tiple reactions was purified from agarose gels and cotransformed Hsc70-bound ATP was hydrolyzed after a 10-min incubation with a gapped version of pT-Ydj1 into ACY17b. To generate the with either yeast or insect-purified T antigen (compare figure 4 gapped pT-Ydj plasmid, a Bgl11 site was introduced just down- to figure 7 in ref. 26). stream of the T antigen J domain with the Quickchange Mu- tagenesis Kit (Stratagene) and oligonucleotides SWF1 and Hsc70 ATPase and Gel-Shift Assays. Single turnover ATPase ex- SWF2. The resulting plasmid was digested with EcoR1 and BglII, periments and E2F gel-shift assays were performed as de- purified, and transformed into yeast. Cells containing plasmids scribed (26). repaired by homologous recombination between the mu- tagenized J domain fragment and the gapped vector (37) were Results selected by plating transformation mixtures onto synthetic com- The T Antigen J Domain Functionally Replaces the J Domain of YDJ1. plete medium lacking uracil. Transformants were subsequently To test our chaperone model for T antigen function and to screened for growth on galactose-containing medium at 25°C, initiate a structure–function analysis of the T antigen J domain, 35°C, and 37°C. Of a total of 1,800 transformants screened, 115 we required a pool of unique J domain mutants. Because candidates were selected. Expression of the T-Ydj1 mutants was traditional methods for isolating mutations are labor intensive or subsequently examined by immunoblot analysis using mAb419 generate compound mutations (19), we developed a genetic that recognizes the T antigen J domain (38). From this analysis, screen that exploited a functional chimeric gene in yeast to Ϸ50% of the mutant proteins were not expressed and were not rapidly identify chaperone-defective point mutations in the T examined further. Plasmids in the remaining temperature- antigen J domain. In principle, our screen should be generally sensitive candidates were rescued from yeast, amplified in bac- applicable to investigators who want to generate a large set of teria, and reintroduced into ACY17b to confirm the loss-of- random mutations in a defined domain in a mammalian gene as function phenotype, resulting in 41 mutants. DNA sequencing long as mutation of a yeast homologue displays a tractable using the Amplicycle sequencing kit (Perkin–Elmer) identified phenotype. 14 unique point mutations in the T antigen J domain.
Load more

Recommended publications
  • Patentability of Human-Animal Chimeras Ryan Hagglund
    Santa Clara High Technology Law Journal Volume 25 | Issue 1 Article 4 2008 Patentability of Human-Animal Chimeras Ryan Hagglund Follow this and additional works at: http://digitalcommons.law.scu.edu/chtlj Part of the Law Commons Recommended Citation Ryan Hagglund, Patentability of Human-Animal Chimeras, 25 Santa Clara High Tech. L.J. 51 (2012). Available at: http://digitalcommons.law.scu.edu/chtlj/vol25/iss1/4 This Article is brought to you for free and open access by the Journals at Santa Clara Law Digital Commons. It has been accepted for inclusion in Santa Clara High Technology Law Journal by an authorized administrator of Santa Clara Law Digital Commons. For more information, please contact [email protected]. PATENTABILITY OF HUMAN-ANIMAL CHIMERAS Ryan Hagglundt Abstract The chimera was a mythological creature with a lion 's head, goat's body, and serpent's tail. Because of recent advances in biotechnology, such permutations on species are no longer the stuff of myth and legend The term "chimera " has come to describe a class of genetically engineered creatures composed of some cells from one species, which thus contain genetic material derived entirely from that species, and some cells from another species, containing only genetic material from that species. Scientists have created a goat- sheep chimera or "geep" which exhibits physical characteristicsof both animals. Likewise, scientists have also used the tools of modern molecular biology to create human-animal chimeras containing both human and animal cells. While none of the human-animal chimeras hitherto created have exhibited significant human characteristics,the synthesis of human-animal chimeras raises significant ethical concerns.
    [Show full text]
  • Molecular Phylogenetic Analysis
    Assignment #2 Physics 498: Statistical Physics of Biological Complexity and Information Molecular Phylogenetic Analysis Date of Submission: 31th October, 2001 Rahul Roy Center for Biophysics and Computational Biology University of Illinois at Urbana-Champaign email: [email protected] Evolve by Borrowing ? Rahul Roy Center for Biophysics and Computational Biology University of Illinois at Urbana Champaign Introduction Molecular evolution over a period of four billion years has resulted in the development of present myriad of species from a hot soup of molecules. It has resulted in the evolution of complex multicellular organisms (Eukaryotes) along with single-celled organisms like prokaryotes at the same time. The question that has baffled scientists for long is: how did this incredible transition from a soup to this complex state take place? The discussion, that still continues, as how life started from the primordial soup is not the emphasis of the present debate, though Stanley Miller showed in, as back as 1950s, that organic chemicals can be synthesized from completely inorganic inputs. It has been proposed based on structural and functional complexity and fossil evidence that prokaryotes must have predated the eukaryotes by at least 1.0-2.0 billion years [Knoll, 1992]. This has led to the notion that eukaryotic cells have evolved from more simple prokaryotic organisms with which they share numerous common (or related) molecules [Margulis, 1970; Zillig, 1991]. Indeed, studies have shown that a number of eukaryotic organelles (namely mitochondria and chloroplasts) bear a close evolutionary relationship to specific groups of prokaryotes (namely α-proteobacteria and cyanobacteria, respectively) [Gray, 1992] So, how did the complex multicellular eukaryotes evolve from prokaryotes? To understand the origin of the eukaryotic cells a number of theories have been proposed.
    [Show full text]
  • BWPP Biological Weapons Reader
    BWPP Biological Weapons Reader Edited by Kathryn McLaughlin and Kathryn Nixdorff Geneva 2009 About BWPP The BioWeapons Prevention Project (BWPP) is a global civil society activity that aims to strengthen the norm against using disease as a weapon. It was initiated by a group of non- governmental organizations concerned at the failure of governments to act. The BWPP tracks governmental and other behaviour that is pertinent to compliance with international treaties and other agreements, especially those that outlaw hostile use of biotechnology. The project works to reduce the threat of bioweapons by monitoring and reporting throughout the world. BWPP supports and is supported by a global network of partners. For more information see: http://www.bwpp.org Table of Contents Preface .................................................................................................................................................ii Abbreviations .....................................................................................................................................iii Chapter 1. An Introduction to Biological Weapons ......................................................................1 Malcolm R. Dando and Kathryn Nixdorff Chapter 2. History of BTW Disarmament...................................................................................13 Marie Isabelle Chevrier Chapter 3. The Biological Weapons Convention: Content, Review Process and Efforts to Strengthen the Convention.........................................................................................19
    [Show full text]
  • Formation and Longevity of Chimeric and Duplicate Genes in Drosophila Melanogaster
    Copyright Ó 2009 by the Genetics Society of America DOI: 10.1534/genetics.108.091538 Formation and Longevity of Chimeric and Duplicate Genes in Drosophila melanogaster Rebekah L. Rogers,1 Trevor Bedford2 and Daniel L. Hartl Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, Massachusetts 02138 Manuscript received May 15, 2008 Accepted for publication November 11, 2008 ABSTRACT Historically, duplicate genes have been regarded as a major source of novel genetic material. However, recent work suggests that chimeric genes formed through the fusion of pieces of different genes may also contribute to the evolution of novel functions. To compare the contribution of chimeric and duplicate genes to genome evolution, we measured their prevalence and persistence within Drosophila melanogaster. We find that 80.4 duplicates form per million years, but most are rapidly eliminated from the genome, leaving only 4.1% to be preserved by natural selection. Chimeras form at a comparatively modest rate of 11.4 per million years but follow a similar pattern of decay, with ultimately only 1.4% of chimeras preserved. We propose two mechanisms of chimeric gene formation, which rely entirely on local, DNA-based mutations to explain the structure and placement of the youngest chimeric genes observed. One involves imprecise excision of an unpaired duplication during large-loop mismatch repair, while the other invokes a process akin to replication slippage to form a chimeric gene in a single event. Our results paint a dynamic picture of both chimeras and duplicate genes within the genome and suggest that chimeric genes contribute substantially to genomic novelty.
    [Show full text]
  • Infectious Enveloped RNA Virus Antigenic Chimeras (Alphaviruses/Random Mutagenesis/Virus Vectors/Protein Engineering/Glycoproteins) STEVEN D
    Proc. Natl. Acad. Sci. USA Vol. 89, pp. 207-211, January 1992 Biochemistry Infectious enveloped RNA virus antigenic chimeras (alphaviruses/random mutagenesis/virus vectors/protein engineering/glycoproteins) STEVEN D. LONDON*, ALAN L. SCHMAUOHNt, JOEL M. DALRYMPLEt, AND CHARLES M. RICE*t *Department of Molecular Microbiology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8230, St. Louis, MO 63110-1093; and tUnited States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21702-5011 Communicated by Edwin D. Kilbourne, October 7, 1991 (receivedfor review August 26, 1991) ABSTRACT Random insertion mutagenesis has been used would allow recovery of infectious chimeric viruses. The to construct infectious Sindbis virus structural protein chime- insertional mutagen was an oligonucleotide encoding an ras containing a neutralization epitope from a heterologous 11-amino acid neutralization epitope (4D4) derived from the virus, Rift Valley fever virus. Insertion sites, permissive for external G2 glycoprotein of Rift Valley fever virus (RVFV). recovery of chimeric viruses with growth properties similar to Both a polyclonal anti-peptide antiserum and a monoclonal the parental virus, were found in the virion E2 glycoprotein and antibody (mAb), mAb 4D4, that react with this epitope on the secreted E3 glycoprotein. For the E2 chimeras, the epitope RVFV virions and also with denatured and reduced RVFV was expressed on the virion surface and stimulated a partially G2 (13, 14) are available. Thus,
    [Show full text]
  • Recombinant VACV Fc Chimera (A.A
    Recombinant VACV Fc Chimera (a.a. 17-258, 18- 258, 100-330) [His] (DAG2641) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Recombinant Viral CCI Fc Chimera antigen, was expressed in Spodoptera frugiperda, Sf 21 (baculovirus). N-terminus Viral CCI (Met17-Val258) & (Pro18-Val258) (Accession # , P19063), C- terminus Human IgG1 (Pro100-Lys330) and 6-His tag, Disulfide-linked homod Nature Recombinant Expression System Insect cells Species VACV Purity > 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. Conjugate His Procedure None Format Lyophilized from a 0.2 μm filtered solution in PBS Preservative None Storage 2-8°C short term, -20°C long term BACKGROUND Introduction Vaccinia virus is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, and which encodes for approximately 250 genes. The dimensions of the virion are roughly 360 × 270 × 250 nm, with a mass of approximately 5-10 fg. Vaccinia virus is well known for its role as a vaccine (its namesake) that eradicated the smallpox disease, making it the first human disease to be successfully eradicated by science. This endeavour was carried out by the World Health Organization under the Smallpox Eradication Program. Post eradication of smallpox, scientists study Vaccinia virus to use as a tool for delivering genes into biological tissues (gene therapy and genetic engineering). Keywords Vaccinia virus vCCI protein, Human IgG1 protein; Orthopoxvirus; Vaccinia virus; 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Chordopoxvirinae; VACV; VV 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 2 © Creative Diagnostics All Rights Reserved.
    [Show full text]
  • Chimeric Brains Consisted of Primatologists and Other Scientists, Ethicists, and Lawyers
    Chimeras Definition Ethical Issues Links Suggested Reading End Notes Definition: What are Chimeras? How and why are they produced? Chimeras are animals composed of cells that originate from two (or more) different species. In the research lab, chimeras are created by introducing cells from one species into the developing embryo or fetus of another. (The name chimera comes from Greek mythology and describes a creature with the head of a lion, the body of a goat, and the tail of a serpent). The first chimeras helped scientists understand questions about developmental biology. A sheep-goat chimera, created in 1984, had the head of a goat and the woolly coat of a sheep.i Chicken-quail chimeras have also been successfully developed.ii,iii Sheep-Goat Chimera Courtesy of Dr. Gary B. Anderson -University of California, Davis Now, researchers are developing human-animal chimeras to study disease processes, test new drugs, and develop organs for future transplant patients. The chimeras are produced by introducing human stem cells into developing animal embryos. The following are some of the major projects utilizing human- animal chimeras underway in the U.S and internationally: Sheep-to-humans organ transplant project: At the University of Nevada at Reno, researchers have added human stem cells to sheep fetuses to create chimeras that they hope will someday serve as a reliable source of organs for liver transplant patients. Some sheep now have livers with up to 80% human cells that produce the compounds normally made by human livers. (The cells are not all in distinct liver lobes but spread throughout the tissue.
    [Show full text]
  • A Computational Analysis to Construct a Potential Post-Exposure Therapy Against Pox Epidemic Using Mirnas in Silico
    orism terr & io B B i f o o d l e Hasan et al., J Bioterror Biodef 2016, 7:1 a f e n n r s u e DOI: 10.4172/2157-2526.1000140 o J Journal of Bioterrorism & Biodefense ISSN: 2157-2526 Research article Open Access A Computational Analysis to Construct a Potential Post-Exposure Therapy against Pox Epidemic Using miRNAs in Silico Mahmudul Hasan, Ewen McLean, and Omar Bagasra* South Carolina Centre for Biotechnology, Department of Biology, Claflin University, Orangeburg, SC 29115, USA Abstract Background: Smallpox was caused by Variola Virus (VARV) and even though it was eradicated in 1979, there exists the possibility of a zoonotic epidemic from Ortho-pox that may be pathogenic to humans. Moreover, VARV may still be used as a bioterrorist weapon. Monkey Pox Virus (MPXV), which is closely related to smallpox, is endemic to certain parts of Africa where sporadic outbreaks in humans are reported. In 2003, an outbreak of human MPXV occurred in the US after the importation of infected African rodents. Since the eradication of smallpox caused by an Ortho Pox Virus (OPXV) related to MPXV, and cessation of routine smallpox vaccination with the live Vaccinia Virus (VACV), there is an increasing population of people susceptible to VARV and perhaps certain other zoonotic OPXV diseases. Were OPXV to be employed as a bioterrorist weapon, there is distinct possibility that it would be deployed as a chimera pox, with OPXV genes being combined with those of other poxviruses (e.g., MPXV, Tatera pox, etc). In such a case, the currently approved smallpox vaccine VACV, may be ineffective.
    [Show full text]
  • Long-Read DNA Metabarcoding of Ribosomal Rrna in the Analysis of Fungi from Aquatic Environments
    bioRxiv preprint doi: https://doi.org/10.1101/283127; this version posted March 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Long-read DNA metabarcoding of ribosomal rRNA in the analysis of fungi from aquatic environments Felix Heeger1,2†, Elizabeth C. Bourne1,2†, Christiane Baschien3, Andrey Yurkov3, Boyke Bunk3, Cathrin Spröer3, Jörg Overmann3, Camila J. Mazzoni2,4‡, Michael T. Monaghan1,2‡ 1Leibniz Institute of Freshwater Ecology and Inland Fisheries (IGB), Müggelseedamm 301, 12587 Berlin, Germany 2Berlin Center for Genomics in Biodiversity Research, Königin-Luise-Str. 6-8, 12489 Berlin, Germany 3Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Inhoffenstr. 7 B, 38124 Braunschweig, Germany 4Leibniz Institute of Zoo- and Wildlife Research (IZW), Alfred-Kowalke-Straße 17, 10315 Berlin, Germany † these authors contributed equally to this work ‡ these authors contributed equally to this work KEYWORDS: aquatic, biodiversity, CCS, chimera formation, eukaryotes, freshwater, fungi, isolates, long DNA barcodes, metabarcoding, mock community, Pacifc Biosciences, SMRT ABSTRACT DNA metabarcoding is now widely used to study prokaryotic and eukaryotic microbial diversity. Technological constraints have limited most studies to marker lengths of ca. 300-600 bp. Longer sequencing reads of several 5 thousand bp are now possible with third-generation sequencing. The increased marker lengths provide greater taxonomic resolution and enable the use of phylogenetic methods of classifcation, but longer reads may be subject to higher rates of sequencing error and chimera formation. In addition, most well- established bioinformatics tools for DNA metabarcoding were originally 10 designed for short reads and are therefore not suitable.
    [Show full text]
  • Chimeric 16S Rrna Sequence Formation and Detection in Sanger and 454-Pyrosequenced PCR Amplicons
    Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Resource Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons Brian J. Haas,1,9 Dirk Gevers,1 Ashlee M. Earl,1 Mike Feldgarden,1 Doyle V. Ward,1 Georgia Giannoukos,1 Dawn Ciulla,1 Diana Tabbaa,1 Sarah K. Highlander,2,3 Erica Sodergren,4 Barbara Methe´,5 Todd Z. DeSantis,6 The Human Microbiome Consortium, Joseph F. Petrosino,2,3 Rob Knight,7,8 and Bruce W. Birren1 1Genome Sequencing and Analysis Program, The Broad Institute, Cambridge, Massachusetts 02142, USA; 2Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas 77030, USA; 3Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; 4The Genome Center, Washington University School of Medicine, St. Louis, Missouri 63108, USA; 5Human Genomic Medicine, J. Craig Venter Institute, Rockville, Maryland 20850, USA; 6Earth Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA; 7Department of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado 80309, USA; 8Howard Hughes Medical Institute, University of Colorado, Boulder, Colorado 80309, USA Bacterial diversity among environmental samples is commonly assessed with PCR-amplified 16S rRNA gene (16S) se- quences. Perceived diversity, however, can be influenced by sample preparation, primer selection, and formation of chimeric 16S amplification products. Chimeras are hybrid products between multiple parent sequences that can be falsely interpreted as novel organisms, thus inflating apparent diversity. We developed a new chimera detection tool called Chimera Slayer (CS). CS detects chimeras with greater sensitivity than previous methods, performs well on short se- quences such as those produced by the 454 Life Sciences (Roche) Genome Sequencer, and can scale to large data sets.
    [Show full text]
  • Detection of a New Resistance-Mediating Plasmid Chimera in a Blaoxa-48-Positive Klebsiella Pneumoniae Strain at a German University Hospital
    microorganisms Article Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital Julian Schwanbeck 1,† , Wolfgang Bohne 1,†, Ufuk Hasdemir 2 , Uwe Groß 1, Yvonne Pfeifer 3, Boyke Bunk 4, Thomas Riedel 4,5, Cathrin Spröer 4, Jörg Overmann 4,5, Hagen Frickmann 6,7,‡ and Andreas E. Zautner 1,*,‡ 1 Institute for Medical Microbiology, University Medical Center Göttingen, 37075 Göttingen, Germany; [email protected] (J.S.); [email protected] (W.B.); [email protected] (U.G.) 2 Department of Medical Microbiology, School of Medicine, Marmara University, 34854 Istanbul, Turkey; [email protected] 3 Robert Koch Institute, FG13 Nosocomial Infections and Antibiotic Resistance, 38855 Wernigerode, Germany; [email protected] 4 Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany; [email protected] (B.B.); [email protected] (T.R.); [email protected] (C.S.); [email protected] (J.O.) 5 German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124 Braunschweig, Germany 6 Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital Hamburg, 20359 Hamburg, Germany; [email protected] Citation: Schwanbeck, J.; Bohne, W.; 7 Institute for Medical Microbiology, Virology and Hygiene, University Medicine Rostock, Hasdemir, U.; Groß, U.; Pfeifer, Y.; 18057 Rostock, Germany Bunk, B.; Riedel, T.; Spröer, C.; * Correspondence: [email protected]; Tel.: +49-551-39-65927 Overmann, J.; Frickmann, H.; et al. † These authors contributed equally to this work. Detection of a New ‡ These authors contributed equally to this work. Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Abstract: Mobile genetic elements, such as plasmids, facilitate the spread of antibiotic resistance Klebsiella pneumoniae Strain at a genes in Enterobacterales.
    [Show full text]
  • Human-Animal Chimeras
    Issue Brief June 2021 | No. IF21F01 Human-Animal Chimeras: Unethical and Unnecessary by Mary Szoch, M.Ed. Key Points n the United States, the ethical considerations regarding Human-animal chimeras are human-animal chimeras and human embryo research are creatures that are part human and part animal. Since 1979, intertwined. Understanding the regulations on human- there has been a restriction, Ianimal chimeras the United States ought to have requires a known as the 14-Day Rule, on developing this type of review of the United States’ policies on human embryo creature past 14 days gestation research, an overview of what human-animal chimeras are, an in vitro. analysis of the purported benefits of human-animal chimera In 2016, after scientists gained the ability to develop an research, and a synopsis of the ethical questions posed by embryo in vitro beyond nine creating these creatures. days, the National Institutes of Health revisited the 14-Day Rule, but under the pro-life Trump administration, the Rule The serious ethical concerns about the creation of human- was kept in place. animal chimeras and the lack of any beneficial scientific After a partnership with China advancements from chimera experiments make it clear that created the first human- primate chimera, the NIH, human-animal chimeras are unethical and unnecessary. under the Biden administration, opted to once again review the 14-Day Rule. Senators recently voted along party lines against banning the creation of human- animal chimeras through legislation. This report can be read online at frc.org/chimeras 801 G. St. NW Washington, D.C.
    [Show full text]